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A Direct Role for NKG2D/MICA Interaction
in Villous Atrophy during Celiac Disease
sorption. Its only current treatment is a lifelong exclusion
of gluten from the diet.
CD is characterized by the infiltration of the small
Sophie Hu¨e,1 Jean-Jacques Mention,2
Renato C. Monteiro,4 ShaoLing Zhang,1,7
Christophe Cellier,5 Jacques Schmitz,3
intestine by a T cell “cocktail” composed mainly of acti-Virginie Verkarre,2 Nassima Fodil,6
vated CD4 T cells in the lamina propria and CD8 T cellsSeiamak Bahram,6 Nadine Cerf-Bensussan,2
in the epithelium (for review see Shan et al., 2002; Sollid,and Sophie Caillat-Zucman1,*
2002). It occurs in genetically susceptible individuals1Equipe Avenir INSERM
expressing the HLA-DQ2 or -DQ8 molecules, which are2 INSERM EMI-0212 and
the restriction elements for CD4 T cells recognizing glia-3 Service de Gastroente´rologie Pe´diatrique
din peptides (Dieterich et al., 1997; Lundin et al., 1993;Hoˆpital Necker-Enfants Malades
Molberg et al., 1998; Shan et al., 2002). The role of CD875015 Paris
TCR or TCR intraepithelial lymphocytes (IEL) re-France
mains one important unsolved question. Indeed, this IEL4 INSERM E-0225
infiltration, without any other sign of mucosal pathology,Faculte´ Bichat
may represent the first stage of CD (Maki et al., 2003).75018 Paris
Furthermore, disruption of intraepithelial lymphocyteFrance
homeostasis in CD can ultimately lead to the emergence5 De´partement d’He´patoGastroEnte´rologie
of the lymphoid malignancies characteristic of CD, asHoˆpital Europe´en Georges Pompidou
recently demonstrated by the study of refractory celiac75015 Paris
sprue (RCS). This severe enteropathy complicates CDFrance
in a small subset of patients primarily or secondarily6 INSERM-CreS
refractory to a strict gluten-free diet. Now considered aCentre de Recherche d’Immunologie et d’He´matologie
low-grade intraepithelial lymphoma, it is characterizedStrasbourg 67000
by a massive intraepithelial infiltration by atypical CD7France
IELs with clonal TCR rearrangement and intracellular
CD3 chain but no surface CD3 (sCD3)/TCR complexes
(Cellier et al., 1998, 2000). Although IELs from CD and
Summary RCS are able to kill epithelial cells through the perforin/
granzyme pathway (Di Sabatino et al., 2001; Mention et
MICA molecules interact with the NKG2D-activating al., 2003), the effector and target cell receptors involved
receptor on human NK and CD8 T cells. We investi- in this destruction have yet to be unearthed to shed light
gated the participation of the MICA/NKG2D pathway on the apparent complex pathophysiology of this disease.
in the destruction of intestinal epithelium by intraepi- The human MICA and MICB proteins (Bahram et al.,
thelial T lymphocytes (IEL) in Celiac disease and its 1994) are nonconventional HLA class I molecules that
premalignant complication, refractory sprue. We show serve as ligands for the activating NKG2D receptor ex-
that MICA is strongly expressed at epithelial cell sur- pressed at the surface of all CD8 T cells, T cells,
face in patients with active disease and is induced and most NK cells. Under normal conditions, expression
of MIC molecules is restricted to intestinal and thymicby gliadin or its p31-49 derived peptide upon in vitro
epithelium (Groh et al., 1996; Hue et al., 2003), but ischallenge, an effect relayed by IL-15. This triggers
stress inducible in various epithelial cells and is upregu-direct activation and costimulation of IEL through en-
lated in tumors (Groh et al., 1999; Vetter et al., 2002)gagement of NKG2D, leading to an innate-like cytotox-
and upon exposure to intracellular pathogens (Das eticity toward epithelial targets and enhanced TCR-
al., 2001; Groh et al., 2001). MICs function as signals ofdependent CD8 T cell-mediated adaptive response.
cellular distress and trigger a range of immune effectorVillous atrophy in Celiac disease might thus be as-
mechanisms including cellular cytotoxicity, cytokine se-cribed to an IEL-mediated damage to enterocytes in-
cretion, and cellular proliferation (for review see Bahram,volving NKG2D/MICA interaction after gliadin-induced
2000; Vivier et al., 2002). In TCR CD8 T cells, NKG2D/expression of MICA on gut epithelium. This supports
MIC engagement delivers a costimulatory signal thata key role for MIC/NKG2D in the activation of intraepi-
complements TCR-mediated antigen recognition on tar-thelial immunity in response to danger.
get cells (Groh et al., 2001). In NK cells, NKG2D acts
as an activating immunoreceptor, which can transduce
Introduction positive intracellular signaling (Bauer et al., 1999; Cos-
man et al., 2001; Pende et al., 2001). Lastly, MIC can
Celiac disease (CD) is a T cell-mediated immune disease be recognized by intraepithelial or tumor-infiltrating T
of the small intestine triggered by wheat gliadin, which cells and is able to deliver both a TCR-dependent and
leads to villous atrophy, cryptic hyperplasia, and malab- an NKG2D-dependent costimulatory signal for a subset
of V1  T cells (Wu et al., 2002).
NKG2D cell surface expression requires association*Correspondence: caillat@necker.fr
with the adaptor molecule DAP10 (Wu et al., 1999), which7 Present address: Department of Endocrinology, Second Affiliated
Hospital of Sun Yat-Sen University, Guangzhou 510275, China. contains a consensus YxxM tyrosine-based motif in its
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To determine whether MICA was expressed at the
cell surface of villous epithelium, we next isolated gut
epithelial cells from fresh intestinal biopsy samples and
analyzed them by flow cytometry (Figure 2, left). In con-
trols and treated CD patients, the percentage of epithe-
lial cells expressing MICA at their surface was very low
(mean  SEM, 2.5%  0.9% in controls and 3.6% 
2.6% in treated CD), suggesting that most immunoper-
oxidase staining observed in normal gut biopsies de-
tects intracellular MICA. Indeed, staining of epithelial
cells isolated from normal jejunum revealed intracellular
MICA in a majority of permeabilized cells, while this
antigen was not detected by surface staining (upper
right quadrant). In contrast, in active CD and RCS pa-
tients, the percentage of epithelial cells expressing
MICA at their surface was significantly increased (mean
29.8%  5% in active CD and 32%  18.6% in RCS,
Figure 1. MICA Protein Expression Is Increased in Small Intestinal p  0.008 for comparison between the four groups, non-
Mucosa of CD Patients parametric ANOVA test). This percentage even reached
Paraffin-embedded biopsy sections from a non-CD control (A), ac- 87% in patient BER who presented a particularly severe
tive CD patient (B), CD patient on a gluten-free diet (C), and patient RCS with 90% of circulating mononuclear cells sharing
with RCS (D). Magnification 100	.
the same aberrant phenotype and clonality as IELs.
These results indicate that MIC, normally expressed in
the cytoplasm of gut epithelial cells, is induced at theircytoplasmic domain. In human cells, engagement of
surface during the course of CD, and this appears toNKG2D results in tyrosine phosphorylation of DAP10,
correlate with the severity of the disease.and recruitment and activation of the p85 subunit of
phosphatidylinositol 3-kinase (PI3K) (Billadeau et al.,
2003). In mice, however, the distinct functions of NKG2D Gliadin Induces MICA Expression in the Intestine
of Treated CD Patientsin NK cells and CD8 T cells is due, at least in part, to
the existence of two NKG2D protein species encoded To assess whether gliadin, the CD-triggering factor, may
induce expression of MICA in the small intestine, freshby distinct mRNA splice isoforms and to their asso-
ciation with either DAP10 or the immunoreceptor tyro- biopsies were incubated for 4 to 48 hr with or without
a peptic-tryptic digest of gliadin in an organ culturesine-based activation motif (ITAM)-containing KARAP/
DAP12 adaptor protein (Diefenbach et al., 2002; Gilfillan chamber prior to staining (Maiuri et al., 1998) (Figure 3
and Table 1). In biopsies from healthy individuals (n 
et al., 2002).
The remarkably restricted expression of MIC in the 5), gliadin did not modify MICA expression. In untreated
CD patients (n 
 3), the already strong expression ofintestinal mucosa, its induction by cellular distress, and
its recognition by NKG2D at the surface of CD8 and MICA and the severe epithelial alterations induced by
the culture with gliadin precluded any analysis. By con- T cells suggested a possible role of MIC/NKG2D
interaction in the IEL-mediated destruction of gut epi- trast, in treated patients on gluten-free diets (n 
 9), a
clear increase in MICA expression was observed onthelial cells in the course of CD.
both epithelium and lamina propria cells (Figure 3D).
This effect was observed very early (within 4 hr of in vitroResults
challenge) and was maximal after 24 hr of organ culture.
No modification of MICA expression was induced by aMIC Is Overexpressed in the Small Intestine
of Patients with Active CD peptic-tryptic digest of bovine serum albumin (BSA).
These data indicate that gliadin can induce MICA proteinStaining of duodenal sections from four normal control
subjects who had undergone biopsies for diagnostic expression in intestinal epithelial cells from treated
CD patients.purpose showed that MIC was expressed in villous epi-
thelial cells, as originally described (Groh et al., 1996). To understand the mechanisms of MICA induction by
gliadin, we investigated the effect of two gliadin-derivedHowever, this staining was only of moderate intensity,
heterogeneous within and between villi and seemed peptides known to mediate distinct effects. The 33-mer
p57-89 gliadin peptide activates the CD4-mediatedmainly intracellular (Figure 1A). By contrast, in active CD
patients with villous atrophy (n 
 6), epithelial expres- adaptive immune response in CD patients: it contains
three concatemerized immunodominant T cell epitopession of MICA was not only much more intense but also
diffuse from the surface to the bottom of the crypts and and was shown to efficiently stimulate CD4 T cell lines
derived from the intestine of CD patients (Shan et al.,accompanied by staining of mononuclear cells within
the lamina propria (Figure 1B). Remarkably, in CD pa- 2002). The p31-49 peptide, known to induce small intes-
tinal damage in vitro and in vivo in CD patients, is nottients who had recovered normal histology under gluten-
free diets (n 
 5), staining pattern returned to normal recognized by CD4 intestinal T cells but was recently
reported to activate the innate immune system (Maiuri(Figure 1C). However, in RCS patients under strict glu-
ten-free diets (n 
 4), MICA expression was even more et al., 2003). The hSA peptide was used as a control.
p31-49 induced a strong expression of MICA in the epi-intense and diffuse than in active CD (Figure 1D).
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Figure 2. Induction of MIC at the Surface of
Gut Epithelial Cells and Expression of NKG2D
on Intraepithelial Lymphocytes in Active CD
and RCS
Flow cytometry analysis of epithelial cells and
IELs freshly isolated from duodenal biopsies
in control subjects (n 
 4), treated CD (n 

5), active CD (n
 4), and RCS (n
 4) patients.
The numbers indicate the percentage of
gated cells. A representative experiment from
each group is shown.
Left: ESA-positive epithelial cells stained with
PE-labeled anti-MICA SR116 mAb. In the up-
per right quadrant, intracellular staining of
permeabilized cells is shown in the same con-
trol subject.
Right: CD2 CD7 IELs stained with FITC-
labeled MICA tetramers. In parallel to IELs,
staining of PBMC is shown in a treated pa-
tient.
thelium of CD patients. Induction was detectable after Altogether (Table 1), these results demonstrate that
gliadin can induce expression of MICA in the intestineonly 4 hr of culture but was more intense after 12 hr.
The same peptide tested in three controls failed to in- of CD patients. Induction mainly depends on an early
innate response triggered by the p31-49 peptide andduce MIC in two cases. In the third control, a very dis-
creet increase of MICA expression was noticeable. The relayed by IL-15. A contribution of adaptive mechanisms
activated by the immunodominant p57-89 peptide in annonimmunodominant p57-89 peptide was a much less
efficient inducer of MIC. Induction was detectable only IL-15-independent way can, however, be detected in a
subset of patients.in two out of six tested patients, and this peptide had
no effect in the controls. The hSA control peptide had
no effect on MICA expression.
IELs Can Lyse Epithelial Targets via NKG2DTo more deeply investigate the molecular mecha-
Since epithelial cells of the small intestine express MICAnisms involved in MICA induction by gliadin peptides,
after exposure to gliadin, they could become the targetswe next studied the role of IL-15. This cytokine, overex-
of NKG2D-positive IELs during active CD. We first con-pressed in the intestine of CD patients, not only medi-
firmed by flow cytometry analysis that NKG2D was ex-ates epithelial damage but also sustains a persistent
pressed on most freshly isolated IELs, as describedactivation of the adaptive immune system (Maiuri et al.,
(Roberts et al., 2001) (Figure 2, right). The percentage2000). Our previous data suggested that IL-15 can be
of IELs able to bind MICA tetramers was not significantlyupregulated upon gliadin challenge in biopsies of
different between non-CD controls, treated, or untreatedtreated CD patients (Di Sabatino et al., 2001; Mention
CD patients (77%  10%, 79%  4%, and 82%  6%,et al., 2003). Furthermore, it was shown that p31-49
respectively, mean 82.5%), while it reached 98%  1%stimulates IL-15 production in lamina propria dendritic
in RCS patients (p 
 0.01 compared to the three othercells and macrophages of CD patients (Maiuri et al., 2003).
groups, ANOVA test). The level of MICA tetramer bindingAs shown in Figure 3, IL-15 induced a strong expression
to IELs, as defined by mean fluorescence intensity, wasof MICA in biopsies from both treated CD patients and
comparable in controls and CD patients whatever theirhealthy controls. Moreover, culturing biopsies from
status and the percentage of MICA-positive epithelialtreated CD patients in the presence of neutralizing anti-
cells.IL-15 antibody abrogated the p31-49-induced expres-
We then determined whether IELs from active CD orsion of MICA, while it had no effect on the p57-89-
RCS could mediate killing of target cells throughmediated MICA induction. Consistent with a direct effect
NKG2D/MICA interaction. Because the small number ofof IL-15 on enterocytes, some accumulation of intracel-
IELs directly recovered from intestinal biopsies pre-lular MICA was observed after stimulation of HT29, T84,
vented extensive further experiments, we derived T celland Caco2 epithelial cell lines cultured for 4–24 hr in
lines from these very biopsies in nine patients (five activethe presence of IL-15. This effect remained, however,
CD and four RCS) with IL-15 as previously describedmodest, perhaps due to the already high constitutive
(Di Sabatino et al., 2001; Mention et al., 2003). Theseexpression of MIC and IL-15 in these cell lines. In con-
trast, gliadin had no effect (data not shown). cell lines were then tested in a redirected lysis assay
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against FcR-bearing P815 target cells (Bauer et al.,
1999). Cell lines from active CD patients expressed a
classical TCR CD3 CD8 NKG2D phenotype at
the time of testing. Crosslinking NKG2D alone on these
IEL lines had no or only minor effect even at a 30:1
effector:target cell ratio, although TCR engagement
by 1 ng/ml of anti-CD3 induced strong target cell lysis.
However, crosslinking NKG2D significantly augmented
CD3-mediated redirected lysis when using suboptimal
concentration of anti-CD3 (0.01 ng/ml), although the effi-
ciency of lysis varied from line to line (Figure 4A). These
results indicate that in T cell lines from active CD pa-
tients, NKG2D functions as a costimulatory receptor in
a conventional way, similar to what has been described
in CD8 T cells.
Surprisingly, however, when redirected cytotoxicity
assays were repeated with the same CD8 T cell lines
from two different patients at various kinetic points of
the cell culture, some differences appeared. Indeed, at
very narrow time points, NKG2D-mediated lysis was
sometimes observed at day 15 of the cell culture, while
it was not detected the day before (Figure 4B). This
phenomenon was transient, as CD8 T cells rapidly re-
covered their classical cytotoxicity profile 4 days later.
It thus appears that in particular circumstances, NKG2D
alone can mediate IEL cytotoxicity.
We then analyzed the four cell lines from RCS patients,
which all expressed the aberrant sCD3 CD7 NKG2D
phenotype. In all cases, NKG2D was able to mediate
alone the killing of P815 target cells, even at a low ef-
fector:cell ratio (Figure 4C). Although the percentage of
target cell lysis varied depending on the patient (21%–
93% at 30:1 E:T ratio, mean 51.3%), this NKG2D-medi-
ated killing was constant and maintained over time.
Thus, in sCD3 CD7 IELs, NKG2D has a direct activat-
ing function triggered by engagement of its ligand MICA,
similar to what is observed in NK lines (Bauer et al.,
1999).
To confirm that IELs from RCS can indeed mediate
killing of enterocytes via NKG2D, we performed a direct
cell-mediated cytotoxicity assay on epithelial target
cells. As previously shown, all cell lines from RCS pa-
tients were able to kill MICA-positive HT29 or HeLa epi-
thelial cell lines even at a low effector:cell ratio (Di Saba-
tino et al., 2001; Mention et al., 2003). In the case of
patient BER (Figure 4D), anti-NKG2D mAb fully inhibited
the lysis by more than 60%. Since in this patient, 87%
of intestinal epithelial cells expressed surface MICA, the
NKG2D/MICA pathway seems to be directly involved in
the massive destruction of the gut epithelium, leading
to villous atrophy. Interestingly, one subclone of this
patient’s cell line lost surface NKG2D expression. Both
redirected lysis of P815 cells and cell-mediated cytotox-
icity of epithelial target cells were completely abolished
(data not shown), confirming that the cytolytic effect of
IELs is fully mediated by NKG2D signaling in this patient.Figure 3. MICA Expression Is Induced by Gliadin or Gliadin-Derived
Peptides in the Small Intestine Mucosa of CD Patients In the other RCS patients, however, inhibition by anti-
NKG2D did not exceed 35%, suggesting that killing ofBiopsy specimens from healthy controls (A, C, E, G, and I) and CD
patients on a gluten-free diets (B, D, F, H, J, and K–N) were incubated
for 12 hr in medium alone (A and B) or in presence of peptic-tryptic
digest of gliadin (C and D) or p31-49 gliadin peptide (E and F), p57-
SR99 anti-MIC mAb. In (A) and (N), weak nonspecific staining of89 gliadin peptide (G and H), IL-15 (I and J), p31-49 plus anti-IL-15
neutralizing mAb (K), p57-89 plus anti-IL-15 mAb (L), peptic-tryptic red blood cells is observed in some lamina propria blood vessels.
Magnification 160	.digest of BSA (M), and hSA control peptide (N) prior to staining with
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Table 1. Gliadin-Induced MICA Expression in the Intestine of Healthy Controls and Treated CD
Peptic-Tryptic p31-49 
Digest of Gliadin p57-89 p31-49 IL-15 anti-IL-15 mAb
Controls 0/5 0/3 1*/3 3/3 n.d.
Treated CD patients 7/7 2*/6 7/7 4/4 0/3
Results are given as the number of subjects with increased expression of MICA among five healthy controls and nine treated CD patients
after 12 hr of in vitro organ culture in the presence of gliadin or gliadin-derived peptides.
*Weak MICA induction.
n.d., not done.
epithelial cells involves the engagement of additional conventional IELs, and a TCR-mediated signal is re-
quired for complete activation. In the more severe formtriggering receptor(s). Indeed, in agreement with this
hypothesis, we observed that high concentration of IELs RCS, NKG2D mediates by itself a direct activating signal
in abnormal sCD3 IELs, endowing these cells withfrom the five active CD patients were also able to medi-
ate direct epithelial cell lysis (100:1 E:T ratio) (Figure 4E). strong epithelium killing capacity.
This cytotoxic activity was only partly inhibited by anti-
NKG2D mAb (range 4.7%–31.5% of inhibition), arguing High Levels of Soluble MIC Molecules Are Present
in the Serum of Active CD Patientsin favor of the participation of other activating receptors
in this antigen-independent killing. The release of a soluble form of MICA (sMICA) in the
serum of some cancer patients was recently reportedHuman NK and CD8 T cells use the DAP10-PI3K path-
way for NKG2D activation. To determine whether the (Groh et al., 2002; Salih et al., 2002). We tested the
presence of sMICA in the serum of CD patients with asame pathway is utilized by sCD3 IELs from RCS, we
measured the lytic activity of the cell line from patient highly sensitive sandwich ELISA (Figure 5A). Sera from
24 healthy individuals or control patients with non-CDBER, which is largely dependent on NKG2D in the pres-
ence of 1 M of the PI3K inhibitor LY 294002. In both enteropathy were all negative. Nineteen of 54 CD sera
(35.2%) contained sMICA (range 0.45–370 ng/ml, meanredirected lysis assay and cell-mediated cytotoxicity ex-
periments toward epithelial cells, lysis was abrogated 57 ng/ml). Among these patients, sMICA was detected
in 16 of 32 (50%) untreated patients on gluten-containingby more than 80%, indicating that the PI3K pathway
has a key role in the direct cytotoxicity mediated via diets, but in only three of 22 (13.6%, p 
 0.008) patients
on gluten-free diets. Two patients tested sMICA positiveNKG2D (Figures 4B and 4D).
Altogether, these results are evocative of a gradient at the time of diagnosis and became negative after 6
months on gluten-free diets. In addition, among the eightin the potential of NKG2D to mediate epithelial cell de-
struction in the different stages of Celiac disease. In RCS patients on strict gluten-free diets, three had
sMICA. Therefore, the presence of sMICA is correlativeactive CD, NKG2D mainly plays a costimulatory role on
Figure 4. NKG2D-Mediated Cytotoxicity of
IELs in Active CD and RCS
(A–C) Redirected cytotoxicy of FcR P815
cells by IEL cell lines. Results represent tripli-
cate of lysis for each cell line in a given experi-
ment. (A) IEL cell lines from five different active
CD patients are tested at a 30:1 effector:tar-
get cell ratio, in the presence of anti-CD3 mAb
(0.01 ng/ml) and/or anti-NKG2D mAb (1g/ml),
mAb, or isotype control IgG1. (B) IEL cell line
from one representative patient with active
CD, tested at different kinetic time points of
the cell culture (day 14, 15, 19, and 26), shows
transient capacity in the NKG2D-mediated
killing of P815 cells. (C) NKG2D-mediated kill-
ing of P815 cells by IEL cell lines from four
patients with RCS in the presence of control
IgG1 or anti-NKG2D mAb (effector:target cell
ratio 10:1). Lysis is fully abrogated by the PI3K
inhibitor LY 294002 (patient BER, n 
 4).
(D and E) Direct cytotoxicity of MICA-positive
epithelial cells by IEL cell lines. (D) Cytotoxic-
ity of HT29 epithelial cells by IEL cell line from
RCS patient BER (10:1 E:T ratio) in presence
or absence of isotype control IgG1, anti-
MICA, or anti-NKG2D mAb or LY294002. (E)
IEL cell lines from five active CD patients
show variable direct cytotoxicity of HeLa cells
at high effector:cell ratio (100:1). Lysis is only
weakly abrogated by anti-NKG2D mAb.
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 107 (%) n 
 90 (%)
4 21 (19.6) 18 (20)
5 12 (11.2) 20 (22.2)
5.1 74 (69.2) 50 (55.6)
6 55 (51.4) 40
9 16 (15) 28 (31.1)*
*The number of alleles compared multiplied by p (Pc) not significant.
IELs from active CD, and this is not related to an oppos-
ing activity of soluble IL-15 or TNF. These results sug-
gest an intrinsic capacity of IELs from CD patients to
maintain high levels of NKG2D at their surface.
The MICA5.1 allele is characterized by a frameshift
mutation causing a premature termination codon within
the transmembrane region. In order to rule out the pres-
ence of an aberrant allele of MICA in CD patients respon-
sible for the presence of sMICA and given the conflicting
reports on the role of MICA alleles in susceptibility to
CD (Bilbao et al., 2002; Fernandez et al., 2002; Lopez-
Vazquez et al., 2002), a large series of patients and
controls was genotyped for MICA. We did not find any
significant difference in the allelic distribution of MICA
transmembrane polymorphism between 107 CD pa-
tients and 90 healthy controls (Table 2) or in the fre-
Figure 5. Soluble MICA in the Serum of CD Patients Does Not Down- quency of MICA5.1 homozygosity (19/107, 17.7% versus
modulate NKG2D Levels on IELs
11/90, 12.2%). MICA5.1 frequency was not significantly
(A) Soluble MICA is present in the serum of CD patients. Serum different among patients with serum sMICA compared
samples from 24 healthy individuals, 22 CD patients on gluten-free
to others (71.4% and 60.2%, respectively). Therefore,diets, and 32 untreated CD patients were investigated by ELISA
the presence of sMICA in the serum is not related towith recombinant sMICA*008 as a standard. The data shown are
means of triplicates. Horizontal lines indicate mean value of respec- the presence of a particular MICA genotype.
tive groups. The MICA5.1 variant molecule is aberrantly trans-
(B) Failure of soluble recombinant MICA to downmodulate NKG2D ported to the apical surface of transfected canine kidney
on IEL lines from active CD or RCS patients. Two-color staining of epithelial cells, in contrast to other alleles located at the
IEL cells incubated in the absence or presence of soluble recombi-
basolateral surface (Suemizu et al., 2002). This mightnant MICA (10 g/ml) with or without IL-15 (20 ng/ml). Data are
prevent interaction of MICA5.1-expressing epithelialrepresentative of staining on three different IEL lines.
cells with NKG2D-positive IELs at the basolateral inter-
face. By immunohistochemistry analysis, we did not ob-
serve any difference in the localization of MICA in biopsywith the presence of gluten in the diet but is also de-
samples from active CD or RCS patients expressingtected in a fraction of RCS patients on gluten-free diets.
MICA5.1 at the homozygous or heterozygous state, orThe binding of sMICA induces downmodulation of
not expressing the MICA5.1 allele. These results indicateNKG2D on CD8 T cells and NK cells from cancer patients
that MICA5.1 homozygosity is unlikely to protect human(Groh et al., 2002), which may serve to limit T cell activa-
epithelial cells from their destruction by NKG2D IELs.tion. This raised the question of why NKG2D levels were
maintained at high levels on IELs and circulating CD8
T cells of active CD and RCS patients, even in the pres- Discussion
ence of a high concentration of sMICA. Since IL-15 and
TNF are able to induce NKG2D expression (Groh et al., Villous atrophy in active CD is associated with prominent
enterocyte apoptosis indicative of active epithelial de-2003; Roberts et al., 2001), we measured soluble IL-
15 and TNF in sMICA-containing sera. No significant struction (Ciccocioppo et al., 2001; Monteleone et al.,
2001). However, the processes leading to mucosal dam-amount of these cytokines was detected (below 5 pg/ml
in all tested sera). Furthermore, the NKG2D level at the age remain unclear. Several lines of evidence point to
a contribution of IELs activated via both innate andsurface of IEL cell lines from CD patients was not down-
regulated after incubation with recombinant soluble adaptive arms of the immune system. One the one hand,
HLA-A2-restricted gliadin-specific CD8 T cells haveMICA or whatever exogenous IL-15 was added or not
to the culture medium (Figure 5B). Therefore, at variance been identified in the mucosa of CD patients (Gianfrani
et al., 2003). On the other hand, the antigen-independentwith what is observed on CD4 CD28 T cells from
patients with rheumatoid arthritis (Groh et al., 2003), cytotoxicity of IL-15-stimulated IELs against epithelial
targets points to the role of innate receptors enablingsMICA does not induce NKG2D downmodulation on
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damage of epithelial cells (Ebert, 1998; Mention et al., are increased in the mucosa of patients with active CD
as a consequence of lamina propria mononuclear cell2003; Roberts et al., 2001). Thus, a selective increase
of IELs expressing CD94, the HLA-E-specific NK recep- activation (Daum et al., 1999). Thus, an increased pro-
duction of metalloproteinases in untreated CD patientstor, is observed in active CD (Jabri et al., 2000).
Among other immunoreceptors expressed at the sur- might favor the release of sMIC, as we observed in a
large percentage of our patients. However, the levels offace of IELs, NKG2D is a likely candidate. It behaves as
a sentinel used by CD8 T cells and NK lymphocytes to sMICA in the serum were not correlated to the severity
of histological lesions or clinical symptoms, indicatingdetect cells that have upregulated ligands such as MIC
as a result of cellular insults (Diefenbach and Raulet, 2003). that sMICA cannot be used so far as a marker of activity
or of tolerance to gluten-containing diet. The functionalIn the present study, we show that only a very small
percentage of normal enterocytes express MICA at their consequence of the shedding of MICA remains unclear.
sMICA may play a role in immune escape of humansurface, MIC expression being mostly intracellular. As
NKG2D is constitutively expressed on resident IELs tumors in vivo by inducing NKG2D downregulation,
thereby decreasing the functional capacity of antitumor(Roberts et al., 2001), this low amount of surface MICA
may prevent inappropriate epithelial attack by IELs in effector T cells or NK cells (Groh et al., 2002). We show
that NKG2D levels are comparable on IELs from CD orhealthy individuals. We then show that MIC expression
is strongly increased in active CD and becomes detect- RCS patients with high levels of sMICA and on IELs
from controls or treated patients without sMICA. Sinceable at the surface of duodenal epithelial cells, which
may therefore become targets for NKG2D-expressing NKG2D levels on IELs are upregulated by IL-15 (Roberts
et al., 2001), which is overexpressed during CD, it isIELs. NKG2D functions as a costimulatory signal in CD8
T cells, amplifying antigen-specific signals provided by conceivable that normal levels of NKG2D are maintained
on IELs even in presence of sMIC. Although we didthe TCR. Since CD8 T IELs come into direct contact with
epithelial cells, one may thus expect an enhancement not detect soluble IL-15 in sMICA-containing sera of
patients, it is known that IL-15 is massively exposed atof TCR-mediated destruction of epithelial target cells
through NKG2D/MIC interaction in CD patients. Indeed, the surface of enterocytes during CD (Mention et al.,
2003). Furthermore, surface bound IL-15 can be pre-we show that engagement of NKG2D in T IEL lines from
active CD patients strengthens TCR-mediated, redi- sented in trans to neighboring cells (Dubois et al., 2002),
and is likely to prevent ligand-induced internalization ofrected killing of target cells and allows efficient cytotox-
icity even at limited antigen concentration. Turning our NKG2D. However, the inability of recombinant MICA
to downmodulate NKG2D on IELs from CD patientsattention to RCS, a cryptic intestinal T cell lymphoma
characterized by the presence of an aberrant sCD3 suggests that other mechanisms tending to maintain
NKG2D levels on these cells are likely to be involved.clonal intraepithelial T cell population, we then demon-
strate that MIC/NKG2D interaction can directly induce There is considerable genetic variation in the MICA
gene, with several polymorphisms reported both in thekilling of epithelial target cells by IELs, independently
of any signaling via the TCR. Therefore, as the disease transmembrane and extracellular domains (Fodil et al.,
1999). Allelic variants of MICA substantially differ in theirbecomes resistant to the gluten-free diet, the contribu-
tion of NKG2D in mediating gut epithelium destruction binding affinity for NKG2D (Steinle et al., 2001), which
could have significant effects in the modulation of T cellby IELs shifts from a conventional costimulatory func-
tion in classical CD to an NK-cell receptor-like activating responses. In addition, the MICA gene exhibits a triplet
repeat microsatellite polymorphism in the transmem-signal in RCS. However, the participation of other trig-
gering receptors on IELs remains to be unraveled. First, brane region, which might be associated with variable
secretion of soluble MICA or with aberrant MICA local-NKG2D blockade of spontaneous cytotoxicity of sCD3
RCS cell lines against epithelial cells was only partial in ization at the surface of epithelial cells. We show, how-
ever, that sMICA is detected in patients’ sera regardlessthree-fourths of the tested patients. Second, we ob-
served that in extreme conditions, such as elevated lev- of allelic MICA differences and that MICA is similarly
distributed in gut epithelium of CD patients whateverels of IL-15 and high density of effector cells, IELs from
active CD patients could mediate direct epithelial cell MICA alleles expressed.
The mechanisms leading to upregulation of MIC andlysis in an antigen-independent manner, a phenomenon
previously described as an IL-15-induced bystander ac- its translocation to the surface of epithelial cells in CD
remain to be elucidated. As indicated by intracellulartivation of memory phenotype CD8 T cells (Liu et al.,
2002). This cytotoxic activity was only partly inhibited staining of permeabilized cells, a rapid appearance of
MICA at the cell surface may be due, at least in part,by anti-NKG2D mAb. Engagement of NKG2D, alone or
in combination with other activating receptors on IELs, to redistribution of intracellular protein. In addition, we
show that gliadin rapidly induces MICA expression incould therefore account for a significant part of IEL cyto-
toxicity against epithelial cells, depending on the com- gut epithelium and lamina propria of organ cultures from
treated CD patients. MICA induction appears as a con-plexity of the array of ligands available on target cells, as
recently described for tumor-specific CD8 T cell clones sequence of the inflammatory response induced by glia-
din in the intestine of sensitive individuals rather than(Maccalli et al., 2003).
MIC molecules, like a wide variety of transmembrane as a direct effect of gliadin per se, and one important
relay in the induction of MICA is IL-15. Thus, the MICA-proteins, can be shed as soluble forms in the serum
of patients (Groh et al., 2002; Salih et al., 2002) after inducing effect of gliadin was reproduced by the p31-
49 gliadin-derived peptide. This nonimmunodominantproteolytic cleavage of the membrane-anchored mole-
cules by an as yet unidentified metalloproteinase. Inter- peptide was recently shown to induce IL-15 in innate
immune cells in the lamina propria of CD patients andestingly, levels of metalloproteinases MMP-1 and MMP-3
Immunity
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mers were generated by mixing MICA or MICB monomers with fluo-to induce enterocyte apoptosis, the latter effect being
rochrome-labeled streptavidin in a 4:1 ratio (streptavidin-PE orinhibited by neutralizing IL-15 (Maiuri et al., 2003). Con-
streptavidin-FITC, Pharmingen, San Jose, CA).sistent with this observation, we observed that MICA
induction by p31-49 was inhibited by neutralizing IL-15
during organ culture. Furthermore, IL-15 induced accu- Production of Anti-MICA Monoclonal Antibodies
Anti-MICA monoclonal antibodies were obtained by immunizingmulation of intracellular MICA in epithelial cell lines. To-
mice with purified recombinant MICA*008. SR99 (IgG1), SR104gether with the recent finding that IL-15 induces MICA
(IgG1), and SR116 (IgG2a) mAbs were selected on the basis of bothin human dendritic cells (Jinushi et al., 2003), these data
reactivity against recombinant MICA by ELISA and staining of HT-
support the hypothesis of a direct inducing effect on IL- 29 and HeLa cells by flow cytometry (Hue et al., 2003).
15 on MICA expression. This effect of IL-15 might explain
the intense expression of MICA on the epithelium of
Immunohistochemical AnalysisRCS patients who have no more gluten in their diet
Deparaffinized sections of duodenal biopsies were treated with 40%but retain massively increased levels of IL-15 in their
normal human serum for 20 min at room temperature and incubatedepithelium (Mention et al., 2003). Another gliadin-derived
with the monomorphic anti-MICA SR99 mAb for 1 hr or isotype-
peptide, p57-89, which is a very efficient stimulus of the matched control Ig. Antibody binding was visualized by using biotin-
CD4-mediated adaptive immune response (Shan et al., ylated goat antimouse Ig and the peroxidase EnVision System (Dako,
Carpinteria, CA).2002), had a much more modest effect on MICA induc-
tion at the 12 hr time point chosen, and this effect was
not sensitive to IL-15 blockade. A delayed effect of this
In Vitro Organ Cultures
peptide via other proinflammatory relay is thus not ex- For in vitro challenge, 8–16 fresh biopsy specimens were obtained
cluded. Therefore, the p31-49 peptide could represent for each of nine treated CD patients and five healthy controls, placed
a danger signal in CD patients, through enhanced ex- on iron grids, and cultured for 4, 12, 24, or 48 hr in an organ culture
chamber at 37C as described (Maiuri et al., 1998) in the presencepression of stress proteins, such as MIC. A noticeable
of medium alone, with peptic-tryptic digest of gliadin or bovineincreased expression of hsp65 has been observed in
serum albumin (500 g/ml), or with peptides (200 g/ml) beforejejunal epithelial cells of CD patients (Iltanen et al., 1999),
being fixed in 10% formalin. IL-15 (50 ng/ml) was also tested in four
and the heat-shock protein hsp110, produced by the patients and three controls. In selected samples incubated in the
intestinal epithelium, induces the expression of another presence of peptides, we additionally analyzed the effect of anti-
nonclassical MHC class I molecule, CD1d, on intestinal IL-15 neutralizing monoclonal antibody (10 g/ml, R&D Systems) or
isotype-control antibody.epithelial cells (Colgan et al., 2003).
The gliadin peptides p57-89 (LQLQPFPQPQLPYPQPQLPYPQPIn conclusion, we demonstrate that in CD, gliadin, via
QLPYPQPQPF) (Shan et al., 2002) and p31-49 (LGQQQPFPPQQPYa pathway involving IL-15, induces MICA expression at
PQPQPF) (Maiuri et al., 2003; Matysiak-Budnik et al., 2003) and the
the surface of gut epithelial cells, thereby providing an control human serum albumin hSA peptide (p64-76, VKLVNEVTEF
epithelial target to IELs whose cytotoxic properties are AKT) were synthesized by Epytop (Nıˆmes, France) and were
simultaneously turned on by enterocyte-derived IL-15. 95% pure.
All protein digests and peptides were tested for the absence ofMICA induction will trigger both direct activation and
detectable levels of LPS by the Limulus Amebocyte Lysate assaycostimulation, permitting an early innate-like response
(Charles River Laboratories, Charleston, SC). All reagents wereand a gliadin-specific CD8 T cell-mediated adaptive re-
found to contain0.1 endotoxin U/ml except the control BSA digest,
sponse. In a broader context, interplay between NKG2D/ which contained approximately 5 U/ml.
MIC and IL-15 might be the paradigm of a normal de-
fense mechanism allowing the immediate recruitment
Isolation of Cells and Flow Cytometry Analysisand activation of IELs in response to intestinal aggres-
PBMC from healthy controls were purified by ficoll density centrifu-sions by pathogens. In CD, the control of this primordial
gation. For isolation of IEL and epithelial cells, six to eight freshresponse could help protect mucosa from the damaging
biopsy specimens were pooled and incubated under constant shak-
effects of gliadin. ing in RPMI 1640 (Gibco BRL, Rockville, MD) containing 1% FCS,
1.5 mM MgCl2, and 1 mM ethylen glycol-bis (b-aminoethyl-ether)-
Experimental Procedures N,N,N,N-tetraacetic acid for 30 min at 37C. The supernatant con-
taining the IEL and contaminating epithelial cells was passed
Patients through a nylon filter, and cells were washed twice in PBS supple-
CD was diagnosed in childhood according to EPSGAN criteria mented with 5% human AB serum. Intestinal epithelial cells were
(McNeish et al., 1979) and in adulthood on the basis of villous atro- identified by the expression of epithelial surface antigen (FITC-ESA,
phy, antiendomysium antibodies, and HLA-DQ2 or -DQ8 phenotype. Biomeda, Foster City, CA).
Patients with RCS failed to improve clinically and histologically de- For cell-surface staining of MICA, epithelial cells were incubated
spite strict gluten-free diets for at least 6 months (Cellier et al., with 10 g/ml SR104 mAb or isotype-control antibody at 4C for
2000). The study was performed in accordance with the Declaration 30 min, washed, and then stained with phycoerythrin-labeled goat
of Helsinki and received approval of the local Ethical Committee. antimouse IgG (Caltag, Burlingame, CA). Free FcR were blocked
with a 50 g/ml dilution of mouse Ig before adding FITC-ESA mAb.
Cells In selected experiments, cells were permeabilized by 2% saponin
HeLa (carcinoma of cervix), HT-29, CaCO2, T84 (colonic or colorectal before staining.
adenocarcinoma), and P815 (mouse mastocytoma) cell lines (ATCC, For cell-surface staining of NKG2D, 1–2 	 106 PBMC or 105 IEL
Rockville, MD) were grown in RPMI 1640 supplemented with 10% were incubated at 22C for 90 min with MICA tetramers (at 10 g/ml
fetal calf serum (FCS), glutamine, and antibiotics. of MICA protein), then for 20 min at 4C with antibodies to CD3,
CD8 (BD Pharmingen), TCR, TCR, or CD103 (Beckman Coulter,
Miami, FL). Cells were fixed in PBS with 1% paraformaldehyde andGeneration of Soluble MICA and MICB Molecules
and Fluorescent Tetramers immediately analyzed on a Becton Dickinson FACSCalibur flow cy-
tometer (Becton Dickinson, Palo Alto, CA). Data were analyzed withRecombinant MICA and MICB were produced as secreted proteins
in Sf9 insect cells as previously described (Hue et al., 2003). Tetra- Cell Quest software (Becton Dickinson).
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Cytotoxicity Assays Bahram, S., Bresnahan, M., Geraghty, D.E., and Spies, T. (1994). A
second lineage of mammalian major histocompatibility complexTo derive cell lines from IELs, intestinal biopsy specimens from five
patients with active CD and four patients with RCS were cultured class I genes. Proc. Natl. Acad. Sci. USA 91, 6259–6263.
in 24-well plates (1 biopsy/well) in lymphocyte culture medium con- Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J.H., Lanier, L.L.,
taining IL-15 (20 ng/mL, R&D Systems) as described (Mention et al., and Spies, T. (1999). Activation of NK cells and T cells by NKG2D,
2003). Wells were fed every 3 days with IL-15-containing medium. a receptor for stress-inducible MICA. Science 285, 727–729.
On confluence, cells were transferred into 6-well plates and diluted
Bilbao, J., Martin-Pagola, A., Vitoria, J., Zubillaga, P., Ortiz, L., and
at 106 mL every 3 days in the same medium and their phenotype
Castano, L. (2002). HLA-DRB1 and MHC class 1 chain-related A
monitored by flow cytometry before assessing cytotoxicity.
haplotypes in Basque families with Celiac disease. Tissue Antigens
For redirected lysis assay, cells were washed and incubated for
60, 71–76.
4 hr with 51Cr-labeled FcR P815 target cells at various E:T ratios
Billadeau, D.D., Upshaw, J.L., Schoon, R.A., Dick, C.J., and Leibson,in the presence of the M585 anti-NKG2D mAb (1 g/ml, kindly pro-
P.J. (2003). NKG2D–DAP10 triggers human NK cell-mediated kill-vided by Immunex/Amgen) or mouse IgG1 control and/or anti-CD3
ing via a Syk-independent regulatory pathway. Nat. Immunol. 4,(OKT3) mAb (0.01–100 ng/ml).
557–564.For direct cell-mediated cytotoxicity assay, cells were incubated
for 4 hr with 51Cr-labeled HeLa or HT29 cells at various E:T ratios Cellier, C., Patey, N., Mauvieux, L., Jabri, B., Delabesse, E., Cervoni,
in the presence or absence of recombinant soluble MICA protein J.P., Burtin, M.L., Guy-Grand, D., Bouhnik, Y., Modigliani, R., et al.
(10 g/ml), anti-MICA mAb (10 g/ml), anti-NKG2D M585 mAb (1998). Abnormal intestinal intraepithelial lymphocytes in refractory
(1 g/ml), or isotype control mAb. sprue. Gastroenterology 114, 471–481.
PI3K inhibition experiments were done by pretreating effector Cellier, C., Delabesse, E., Helmer, C., Patey, N., Matuchansky, C.,
cells with the PI3K inhibitor LY 294002 (1 M, Sigma). The mean of Jabri, B., Macintyre, E., Cerf-Bensussan, N., and Brousse, N. (2000).
duplicates of lysis for each cell line was expressed as a percentage Refractory sprue, coeliac disease, and enteropathy-associated
of specific release. T-cell lymphoma. French Coeliac Disease Study Group. Lancet
356, 203–208.
ELISA of Soluble MICA and Modulation Ciccocioppo, R., Di Sabatino, A., Parroni, R., Muzi, P., D’Alo, S.,
of NKG2D on IEL Lines Ventura, T., Pistoia, M.A., Cifone, M.G., and Corazza, G.R. (2001).
Soluble MICA was measured in the serum with a sandwich ELISA Increased enterocyte apoptosis and Fas-Fas ligand system in Celiac
as described (Hue et al., 2003). Recombinant soluble MICA*001 was disease. Am. J. Clin. Pathol. 115, 494–503.
consistently detected at concentration of 0.3 ng/ml. The amount of
Colgan, S.P., Pitman, R.S., Nagaishi, T., Mizoguchi, A., Mizoguchi,IL-15 in patients’ sera was determined by commercial ELISA with
E., Mayer, L.F., Shao, L., Sartor, R.B., Subjeck, J.R., and Blumberg,matched antibody pair in relation to standard pair (R&D Systems).
R.S. (2003). Intestinal heat shock protein 110 regulates expressionModulation of NKG2D levels on IEL cell lines from active CD or
of CD1d on intestinal epithelial cells. J. Clin. Invest. 112, 745–754.RCS patients was examined by flow cytometry after 24 hr of incuba-
Cosman, D., Mullberg, J., Sutherland, C.L., Chin, W., Armitage, R.,tion with soluble recombinant MICA (10 g/ml) in the absence or
Fanslow, W., Kubin, M., and Chalupny, N.J. (2001). ULBPs, novelpresence of IL-15 (20 ng/ml).
MHC class I-related molecules, bind to CMV glycoprotein UL16 and
stimulate NK cytotoxicity through the NKG2D receptor. ImmunityMICA Genotyping
14, 123–133.A total of 107 CD patients and 90 healthy controls, previously de-
scribed (Djilali-Saiah et al., 1998), was MICA genotyped. The tri- Das, H., Groh, V., Kuijl, C., Sugita, M., Morita, C.T., Spies, T., and
nucleotide repeat microsatellite polymorphism in the transmem- Bukowski, J.F. (2001). MICA engagement by human Vgamma2-
brane region of the MICA gene was amplified with PCR primers Vdelta2 T cells enhances their antigen-dependent effector function.
flanking the TM region as described (Mizuki et al., 1997; Sugimura et Immunity 15, 83–93.
al., 2001). The PCR products were electrophoresed in an automated Daum, S., Bauer, U., Foss, H.-D., Schuppan, D., Stein, H., Riecken,
DNA sequencer (Applied BioSystems, Foster City, CA), and the num- E.-O., and Ullrich, R. (1999). Increased expression of mRNA for ma-
ber of microsatellite repeat was estimated automatically using the trix metalloproteinases-1 and -3 and tissue inhibitor of metallopro-
Genescan 672 software. Allelic frequencies were calculated by di- teinases-1 in intestinal biopsy specimens from patients with coeliac
rect counting, and the significance of the association was deter- disease. Gut 44, 17–25.
mined by using the chi-square test. The level of significance was
Di Sabatino, A., Ciccocioppo, R., D’Alo, S., Parroni, R., Millimaggi,set at 0.05, and the correction of Bonferonni for multiple tests was
D., Cifone, M.G., and Corazza, G.R. (2001). Intraepithelial and laminaapplied by multiplying p by the number of alleles compared (Pc).
propria lymphocytes show distinct patterns of apoptosis whereas
both populations are active in Fas based cytotoxicity in coeliac
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